<DOC>
	<DOCNO>NCT00240721</DOCNO>
	<brief_summary>The primary purpose study evaluate effectiveness safety topiramate compare placebo treatment acute manic mixed episodes patient Bipolar I Disorder .</brief_summary>
	<brief_title>A Study Effectiveness Safety Topiramate Treatment Patients With Bipolar Disorder</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled study evaluate effectiveness two dose level topiramate ( 400 600 milligrams/day ) compare placebo treatment acute manic mixed episodes patient Bipolar I Disorder . The trial consist 3 phase : screening period ; double-blind treatment 12 week ; optional open-label period least 6 month . Assessment effectiveness include change baseline Day 21 Young Mania Rating Scale ( YMRS ) total score . Also include 12 week study Global Assessment Scale ( GAS ) , Montgomery-Ã…sberg Depression Rating Scale ( MADRS ) , Brief Psychiatric Rating Scale ( BPRS ) , Clinical Global Impressions ( CGI ) , health-related quality life measure specify time interval . Safety assessment include evaluation adverse event , rate withdrawal study due adverse event , vital sign ( blood pressure pulse ) throughout study , well change clinical laboratory test ( hematology , biochemistry , urinalysis ) , electrocardiogram ( ECGs ) , physical examination specify time . The study hypothesis change baseline Young Mania Rating Scale ( YMSR ) total score Day 21 significantly good topiramate group placebo group . Topiramate tablet ( 50 100 milligram ) placebo , begin 50mg daily increase first week maximum 400mg/day 600mg/day , depend study group . Maximum dosage continue 12 week . Dosage decrease increase investigator 's discretion .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Mood Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Affective Disorders , Psychotic</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Diagnosis Bipolar I Disorder criterion Diagnostic Statistical Manual Mental Diseases , 4th edition ( DSMIV ) , currently experience manic mixed episode DSMIV Structured Clinical Interview criterion experience least one previous manic mixed episode Young Mania Rating Scale ( YMSR ) score &gt; =20 physically healthy female must postmenopausal , surgically sterile , use adequate contraceptive measure , negative pregnancy test . Diagnosis alcohol substance dependence ( exception nicotine caffeine dependence ) DSMIV criterion DSMIV Axis I diagnosis schizoaffective disorder impulse control disorder experience manic episode take antidepressant psychostimulant drug significant untreated unstable medical illness liver , kidney , heart , lung , endocrine system hypersensitivity topiramate previously participate topiramate study .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>topiramate</keyword>
	<keyword>bipolar disorder</keyword>
	<keyword>mood disorder</keyword>
	<keyword>manic state</keyword>
	<keyword>depression</keyword>
	<keyword>manic-depressive psychosis</keyword>
</DOC>